Articles |
Presented in part as an abstract at the Annual Meeting of the American Society of Nephrology, Boston, Mass, November 1993.
From the Veterans Affairs Medical Center and University of Minnesota, Minneapolis.
| Abstract |
|---|
|
|
|---|
Key Words: inducible nitric oxide synthase hypoxia mesangial cells cGMP nitrite/nitrate
| Introduction |
|---|
|
|
|---|
|
We have previously shown that cultured rat mesangial cells possess iNOS, which can be induced by lipopolysaccharide (LPS) and cytokines, resulting in the time-dependent accumulation of NO in the "headspace" (defined as the gas overlying the cells), nitrite and nitrate (NO2-+NO3-) in the media, and cGMP within these cells.6 The present study evaluates the effects of graded hypoxia on iNOS mRNA induction, NO synthesis, postsynthetic NO oxidation and partitioning, and cGMP accumulation, independent of changes in blood flow and shear stress.
| Materials and Methods |
|---|
|
|
|---|
|
Measurement of NO,
NO2-+NO3-, and
cGMP in Mesangial Cell Cultures
NO in the headspace was measured by chemiluminescence. This
assay, based on the observation that ozone interacts with NO to
generate light,19 was performed with a chemiluminescence
analyzer (Sievers 270), as previously described.20
Picomolar amounts of NO can be detected, and the assay is quite
specific for NO.19 20 21 22 23 The entire headspace volume (
250
mL) was suctioned into the chemiluminescence analyzer by using
N2-flushed tubing. The resulting electrical signal,
measured in millivolts with an integration time of 0.06 second, was
converted to picomoles of NO by comparing the signal of the sample with
a calibration curve derived from gas NO standards.22
To measure total NO2-+NO3-, an aliquot of medium was centrifuged to remove cell fragments and was reduced by incubation with E coli nitrate reductase (thus converting NO3- to NO2-).24 NO2- was quantified by reaction with the Greiss reagent (1% sulfanilamide in acetic acid and 0.1% naphthylethylenediamine).18 23 24 In some experiments, samples were divided, and the amount of NO2- was measured both before and after the nitrate reduction step. NO3- was calculated as the difference between the total NO2-+NO3- (after reduction) and NO2- (measured before reduction). This assay can detect NO2- in a range of 5 to 500 µmol/L.
cGMP was extracted from the mesangial cells at the end of the
incubation period by removing all media, washing once, and then
exposing the cells to ice-cold 0.1N HCl for 1 hour. The extraction step
was carried out in the same gas mixture in which the flask had been
incubated. The HCl sample was removed and frozen at -70°C until
assaying for cGMP by radioimmunoassay as described
previously.18 The cell protein remaining in the flask
after HCl extraction was solubilized overnight in 1% SDS and measured
by the method of Lowry et al.25 The amount of
intracellular cGMP from each flask was factored for the amount of
mesangial cell protein in the same flask.18 In some
experiments in which cGMP was measured, the NO synthesis inhibitor
N
-nitro-L-arginine methyl ester
(L-NAME, at 10-3 mol/L) was included in the 24-hour
incubation with LPS to identify the NO-dependent portion of the
intracellular cGMP.
RNA Isolation and Detection of iNOS mRNA
After the incubation of mesangial cells as described above, RNA
was isolated by using the phenol chloroform method.6 26
Total RNA (10 µg per lane) was separated by electrophoresis in a 1%
agarose gel containing (mmol/L) MOPS 20, EDTA 1, and sodium acetate 5
(pH 7.0), along with 2.2 mol/L formaldehyde. After electrophoresis, the
RNA was transferred to nylon membranes (Duralon UV, Stratagene) and
fixed by UV cross-linking (Stratalinker Stratagene). Membranes were
prehybridized for 15 minutes at 65°C with Rapid-Hyb buffer (Amersham)
and hybridized at 65°C for 90 minutes with 32P-labeled
iNOS cDNA probe in the same buffer. Two 15-minute washes in 2x
standard saline citrate (SSC)/0.1% SDS were performed at room
temperature, and a third wash was performed at 60°C for 40 minutes.
These were followed by two washes in 0.1x SSC/0.1% SDS for 40 minutes
at 60°C. Hybridized membranes were exposed to x-ray film, without
enhancing screen, for 3 days. Autoradiographs and ethidium
bromidestained membranes were photographed under UV light, as
previously described.6 27 The 28S and 18S ribosomal RNA
was quantified from the negative by using computer-assisted
videodensitometry to verify the absence of degradation and the presence
of equivalent loading and transfer of the RNA to the membrane. In
addition, the densitometry signal for iNOS mRNA on the autoradiograph
was corrected for that of the 28S RNA on the membrane for each lane, so
that changes in iNOS mRNA signal were corrected for any variability in
loading or transfer of the RNA.27
The cDNA probe for iNOS used in these studies was cloned from mouse macrophages and kindly provided by Drs Carl Nathan and Qiao-wen Xie (Cornell University Medical College).2 The probe was labeled with [32P]dCTP (6000 Ci/mmol, NEN Dupont) by using the random oligonucleotide-primer method (Promega). Only probe with a specific activity of >1x109 cpm/mg DNA was used in these studies.
In Vitro Cell-Free Studies of NO Partitioning and Oxidation
A series of experiments was performed to establish the effect of
O2 tension on the oxidation and partitioning of authentic
NO, independent of the mesangial cell. The purpose of these studies was
to determine the effects of hypoxia alone, independent of
possible effects of hypoxia on NO synthesis that could occur
because of hypoxic alteration of NOS activity or hypoxic inhibition of
production of radicals and peroxides by the mesangial cell. A bolus of
authentic NO (0.5 mL of 0.2 mmol/L NO) was added to a glass test tube.
The 10-mL tube, sealed with a rubber stopper, contained 5 mL of
nitrite-poor water (Omnisolve, Curtin Matheson Scientific). The
PO2 of the liquid was controlled by 10
minutes of vigorous bubbling of the water in the vented tubes with
gases containing O2 (95%, 10%, or 2.5%), CO2
(5%), and N2 (balance), resulting in
PO2 values of 500, 80, and 20 mm Hg,
respectively (n=5 each). The headspace in the tube contained 5 mL of
the same gas that had been used to bubble the water. Measurements of NO
were performed on 0.1 mL of headspace and water that were removed in a
gastight syringe 5 minutes after the addition of NO. NO in the media
was added to the glass reflux chamber of the Sievers NO analyzer and
stripped into the gas phase by bubbling the sample with helium for 1
minute. The headspace was then aspirated into the analyzer, and the NO
signal was measured, as previously described.22
Drugs
All drugs and supplies were obtained from Sigma and were of
reagent grade unless otherwise designated in the text.
Statistics
Values are expressed as mean±SEM. Intergroup differences were
assessed by a simple ANOVA with post hoc testing using a Fisher's
protected least significant difference test. A value of
P<.05 was considered statistically significant. Statistics
were performed using STATVIEW 4.01 (Abacus
Concepts) on a Macintosh computer.
| Results |
|---|
|
|
|---|
NO,
NO2-+NO3-, and
cGMP
NO was not detectable in the headspace of control cells incubated
for 24 hours with media only in a normoxic atmosphere (media
PO2, 145 mm Hg) but was stimulated
>500-fold after 24 hours of incubation with LPS (Fig 2A
), similar to a previous report.6 The
increase in headspace NO occurred to a similar degree in normoxia and
severe hypoxia (Fig 2A
). As expected, total
NO2-+NO3- levels were
also significantly stimulated after 24 hours of incubation with LPS.
However, unlike headspace NO, total
NO2-+NO3- levels were
significantly less in LPS-treated cells in severe hypoxia
compared with the normoxic cells (Fig 2B
). It is important to
note that the combination of NO2- and
NO3- in the media is the predominant pool of
NO 24 hours after iNOS induction in mesangial cells (nanomolar
quantities), whereas the NO gas is present in only picomolar
amounts. These initial studies have suggested that hypoxia
alters the L-arginineNO pathway but did not report
whether this was due to decreased iNOS enzyme activity, impaired
induction of iNOS, or other factors that could alter media
NO2-+NO3-.
|
To differentiate among these possibilities and to define the threshold
PO2 at which hypoxic changes in NO may occur,
the effects of intermediate O2 tensions on NO and total
NO2-+NO3- were
measured. As shown in Fig 3A
, NO accumulation in the
headspace is lowest in severe hypoxia
(PO2, 32 mm Hg). The greatest amount
of headspace NO was found in cells with moderate hypoxia
(PO2, 46 mm Hg) and then decreased
again at the two highest oxygen tensions we tested. Total
NO2-+NO3- in the
media was lowest in moderate and severe hypoxia and increased
proportionately at higher PO2 levels (Fig 3B
). cGMP levels (shown in Fig 3C
) were similar in cells incubated with
LPS at all four levels of oxygen tension. Since cGMP is a second
messenger in mesangial cells for substances other than NO, we also
measured cGMP in cells during normoxia and severe hypoxia after
incubation with LPS and the NO synthesis inhibitor L-NAME
(10-3 mol/L). The mean percent inhibition by L-NAME, ie,
the NO-dependent portion of cGMP, was similar in normoxia and severe
hypoxia (36.3±25% and 33.6±6%, respectively; n=3
experiments). Thus, we conclude that neither the total intracellular
cGMP after LPS nor the NO-dependent portion of the cGMP is altered by
hypoxia.
|
Cell-Free In Vitro Experiments
To better understand the effects of hypoxia on the
oxidation and partitioning of NO, we assessed these parameters in a
cell-free in vitro model. When a fixed amount of authentic NO was
introduced into deoxygenated water, the greatest recovery of NO in the
headspace and media occurred under hypoxic conditions (Fig 4
). This confirms that hypoxia, independent of
effects on iNOS activity, facilitates the partitioning of NO to the
headspace. This direct effect of hypoxia on NO partitioning may
explain why headspace NO is increased in renal mesangial cell cultures
during moderate hypoxia, whereas
NO2-+NO3-
accumulation is diminished (as shown in Fig 3
).
|
Alterations in the Oxidation Products of NO
In some experiments, we also measured media
NO2- and NO3-
separately during graded hypoxia. We found that not only did
hypoxia reduce the total
NO2-+NO3- but it also
altered the relative amounts of NO2- and
NO3- found in the media (Fig 5
). In normoxia, (PO2,
140 mm Hg), NO3- made up roughly 60% of the
total
NO2-+NO3-,
whereas NO2- accounted for 40%. However, as
media PO2 decreased from 140 to 32 mm Hg,
the relative contribution of NO2- to total
NO2-+NO3- diminished
to <10% of total
NO2-+NO3- (Fig 5
).
|
iNOS mRNA
We have previously shown that mRNA for iNOS is not detectable by
Northern analysis of total RNA from unstimulated rat mesangial
cells but is markedly induced by 24 hours of incubation with LPS (10
µg/mL).6 In the present study, we examined the
effect of hypoxia on induction of iNOS mRNA by LPS. Fig 6
shows the iNOS signal in mesangial cell RNA from two
separate mesangial cell experiments, each with identical
conditions. Cells were incubated with LPS (10 µg/mL) for 24 hours in
the same four levels of oxygen as for the experiments described above.
Fig 6A
is the autoradiograph after hybridization with cDNA probe
against iNOS; Fig 6B
shows the membrane stained with ethidium bromide.
The same total amount of RNA (15 µg) was loaded in each lane.
Densitometry was performed on the autoradiograph and the stained
membrane from each of these experiments, and the iNOS signal was
corrected for the 28S RNA signal. The results, shown in Fig 6C
,
demonstrate that the induction of iNOS mRNA by LPS was similar at all
four oxygen tensions tested in both experiments. Furthermore, we have
confirmed these findings in two additional experiments (data not
shown).
|
| Discussion |
|---|
|
|
|---|
There are many steps in the L-arginineNO pathway
that must occur for LPS to elicit an effective increase in NO
production and biological activity (Fig 1
). First, the NOS gene must be
transcribed to mRNA, an important regulatory step in the case of iNOS.
Using Northern hybridization with a probe cloned from mouse
macrophages, we have been unable to detect iNOS mRNA in unstimulated
mesangial cells. However, within 4 hours of incubation with LPS, iNOS
mRNA is detectable, and by 24 hours, an eightfold increase in this mRNA
is observed.6 In the present study, similar levels of
iNOS mRNA were seen after 24 hours of incubation with LPS, despite
exposure to different oxygen tensions (Fig 6
). Therefore, we conclude
that hypoxia does not affect the transcription of gene to mRNA
for iNOS.
The second point in the L-arginineNO pathway that we
explored was the direct measurement of headspace NO by
chemiluminescence. This method is quite sensitive and can detect NO in
the headspace of mesangial cells after as little as 6 hours of
incubation with LPS.6 By sampling from the gas above the
mesangial cells and media, we measure only that proportion of the total
NO that manages to escape the cell and that has avoided oxidation in
the media. This is a small fraction of the total NO released from the
cell, as demonstrated by the finding that media
NO2-+ NO3- levels are
200- to 300-fold greater than headspace NO levels (Fig 2
). Furthermore,
the headspace NO content is not solely a function of the rate of NO
synthesis but also its rate and degree of decomposition. Moderate
hypoxia, compared with normoxia, increased headspace NO,
whereas severe hypoxia markedly reduced NO to a level slightly
lower but not significantly different from that of normoxia (Fig 3A
).
This biphasic change in headspace NO can be explained by alterations in
both its partitioning and decomposition. During normoxia, headspace NO
is low because most of it either decomposes while in the media or
rapidly after exposure to the oxygen in the headspace. Our results
suggest that this partitioning and decomposition can be reduced by
limiting the oxygen in the system. The cell-free in vitro studies with
authentic NO confirm that hypoxia favors the survival of NO, so
that it may escape the media and enter the headspace (Fig 4
). Thus,
under conditions of moderate hypoxia, more NO will appear in
the gas phase from a fixed amount of NO, whether that NO is generated
by cells or added to the aqueous phase as "authentic" NO gas in
solution. Furthermore, as a result of the preservation of NO in
hypoxia, less
NO2-+NO3- is
detectable in the media (Fig 3B
). We conclude that although headspace
NO is a very sensitive marker of iNOS function, it is a tiny portion of
the total NO synthesized and is susceptible to changes in partitioning
with variation in ambient PO2. Consequently,
headspace NO should probably not be used in isolation to monitor NO
synthesis.
The total amount of the two major NO oxidation products,
NO2- and NO3-,
were found to progressively decrease with increasing severity of
hypoxia (Fig 3B
). Because, in the presence of
O2, NO rapidly oxidizes to form these products and
because these products are stable enough to accumulate during the 24
hours of incubation, the total
NO2-+NO3- accounts
for the majority of NO produced during the incubation period. Thus, the
finding that severe hypoxia reduced the total
NO2-+NO3- in the
media as well as the NO in the headspace suggests that iNOS activity is
reduced in severe hypoxia. This is consistent with a previous
report that severe hypoxia
(PO2, 28 mm Hg), compared with
normoxia (PO2, 130 mm Hg), markedly
inhibits the activity of isolated bovine cerebellar cNOS16
and the recent findings of McQuillan et al29 demonstrating
a decrease in steady state mRNA for cNOS from human vascular
endothelial cells after 24 to 48 hours of oxygen levels of 20 mm Hg.
In addition, the latter authors also found evidence for decreased NO
generation by these endothelial cells, in that reporter smooth muscle
cells showed little change in cGMP after coincubation with endothelial
cells exposed to hypoxia.
In contrast, we have found that intracellular cGMP levels after incubation with LPS are not different in mesangial cells during normoxia, moderate hypoxia, and severe hypoxia. Rat glomerular mesangial cells possess not only the ability to synthesize NO but also directly respond to it with changes in intracellular cGMP, increases in cell surface area (ie, relaxation), and inhibition of proliferation.17 18 30 We have previously shown that LPS-induced changes in cGMP are mainly dependent on NO by demonstrating significant inhibition of these changes with the NO synthesis inhibitor L-NAME.6 In the present study, the inhibitory effect of L-NAME on cGMP levels after incubation with LPS was similar in normoxia and severe hypoxia. NO interacts with cytosolic guanylate cyclase in these cells, resulting in accumulation of cGMP.31 32 cGMP accounts for most of the physiological effects of NO through its ability to stimulate kinases,33 34 activate potassium channels in vascular smooth muscle,35 36 and lower cytosolic calcium.34 37 It is possible that the cGMP is preserved in hypoxia because the amount of NO produced during hypoxia, even if slightly reduced, exceeds some "threshold" for activation of guanylate cyclase. Alternatively, hypoxia, by enhancing the survival of NO, could yield the same number of NO molecules surviving to activate guanylate cyclase from a smaller amount of NO synthesis. An additional consideration is that the intracellular location of both the iNOS and guanylate cyclase in mesangial cells protects this pathway from changes in oxygen tension in the headspace or media during the time of our incubations. Finally, and most likely, is the conclusion that the actual amount of NO produced from mesangial cell iNOS is not altered by hypoxia, since the cGMP response and mRNA induction are not different. Therefore, the alterations in NO in the headspace and NO2-+ NO3- in the media are mainly due to changes in partitioning and decomposition. Thus, it would seem that the function of cNOS (at severe hypoxia in some cell types) is suppressed by hypoxia,16 29 whereas iNOS is preserved, suggesting differing roles for these isoforms in the pathophysiological effect of hypoxia.
An additional finding in our studies is that in hypoxic environments,
the ratio of the decomposition products NO2-
and NO3- is altered. In normoxia,
65% of
the total NO2-+NO3-
is accounted for by NO3-, whereas in
severe hypoxia 90% is NO3- and <10%
is NO2- (Fig 5
). These findings suggest that
NO is oxidized in a different manner in hypoxia than in
normoxia. It is possible, though unproved, that hypoxia
promotes NO3- formation by increasing the
availability of the forms of hemoglobin and cytochromes, which are
needed to convert NO2- to
NO3-.38 An alternative
explanation is that hypoxia favors the conversion of NO to
peroxynitrite, which is then converted to
NO3-, without the intermediate
formation of NO2-.39 On the basis
of these findings, we conclude that an additional effect of
physiological levels of hypoxia on the
L-arginineNO pathway is to alter the oxidation pathways
for NO. These effects could have implications for the duration of
action and the bioavailability of NO in biological systems.
Furthermore, it suggests that conclusions regarding alterations in the
L-arginineNO pathway in different pathophysiological
states require careful examination and measurement of more than one
point in this pathway.
We have previously demonstrated that glomerular mesangial cells in culture produce NO via an LPS-stimulated iNOS6 and have evidence that the kidney is an important producer of NO in vivo.24 Furthermore, iNOS is found in the juxtaglomerular apparatus,40 arcuate and interlobular arteries, glomeruli, and many parts of the nephron, especially the medullary thick ascending limb and inner medullary connecting duct.41 NO is important in maintaining basal renal vascular tone, glomerular filtration rate,42 and sodium balance, the latter by its natriuretic effect.43 Thus, NO produced by glomerular mesangial cell iNOS could have a number of important actions within the glomerulus and, perhaps by entering the glomerular filtrate, could affect tubular function as well.
Chronic hypoxia can affect vascular remodeling, vessel tone, and function in many organs, including the kidney. Abnormalities in the kidney due to long-term hypoxia include glomerular hypertrophy and focal glomerulosclerosis, although the frequency of clinical renal dysfunction due to chronic hypoxia is unknown. Furthermore, acute hypoxia due to renal hypoperfusion or ischemia is a frequent cause of acute renal failure. Recent studies demonstrated that calcium-independent NO activity was increased in isolated proximal tubules after 15 minutes of severe hypoxia and increased further 35 minutes after reoxygenation.44 Inhibition of the NO with L-NAME reduced the hypoxia/reoxygenation injury in these cells. Thus, given the work of others along with the findings of the present study, it is quite possible that NO is important in the pathophysiological effects of hypoxia on the kidney.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received September 14, 1994; accepted March 13, 1995.
| References |
|---|
|
|
|---|
-interferon. J Immunol. 1987;139:518-525. [Abstract]
2.
Xie Q, Cho HJ, Swiderek KM, Lee TD, Ding A, Troso T,
Nathan C. Cloning and characterization of inducible nitric oxide
synthase from mouse macrophage. Science. 1992;256:225-228.
3. Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;191:89-94. [Medline] [Order article via Infotrieve]
4.
Geller DA, Lowenstein CJ, Shapiro RA, Nussler
AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar
TR. Molecular cloning and expression of inducible nitric oxide
synthase from human hepatocytes. Proc Natl
Acad Sci U S A. 1993;90:3491-3495.
5.
Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ,
Shapiro RA, Wang SC, Simmons RL, Billiar TR. Cytokines,
endotoxin, and glucocorticoids regulate the expression of inducible
nitric oxide synthase in hepatocytes. Proc
Natl Acad Sci U S A. 1993;90:522-526.
6. Shultz PJ, Archer SL, Rosenberg ME. Inducible nitric oxide synthase mRNA and activity in glomerular mesangial cells. Kidney Int. 1994;46:683-689. [Medline] [Order article via Infotrieve]
7. Warren JB, Maltby NH, McCormack D, Barnes PJ. Pulmonary endothelium-derived relaxing factor is impaired in hypoxia. Clin Sci. 1989;77:671-676. [Medline] [Order article via Infotrieve]
8. Adnot S, Raffestin B, Eddahibi S, Braquet P, Chabrier P-E. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest. 1991;87:155-162.
9.
Russ RD, Walker BR. Maintained
endothelium-dependent pulmonary vasodilation following
chronic hypoxia in the rat. J Appl
Physiol. 1993;74:339-344.
10.
Isaacson TC, Hampl V, Weir EK, Nelson DP, Archer SL.
Increased endothelium-derived nitric oxide in
hypertensive pulmonary circulation of chronically hypoxic rats.
J Appl Physiol. 1994;76:933-940.
11.
Groves BM, Reeves JT, Sutton JR, Wagner PD, Cymerman A,
Malconian MK, Rock PB, Young PM, Houston CS. Operation Everest
II: elevated high-altitude pulmonary resistance unresponsive to
oxygen. J Appl Physiol. 1987;63:521-530.
12. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med. 1991;324:1539-1547.[Abstract]
13.
Johns RA, Linden JM, Peach MJ.
Endothelium-dependent relaxation and cyclic GMP accumulation in
rabbit pulmonary artery are selectively impaired by moderate
hypoxia. Circ Res. 1989;65:1508-1515.
14. Archer SL, Tolins JP, Raij L, Weir EK. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Commun. 1989;164:1198-1205. [Medline] [Order article via Infotrieve]
15.
Hampl V, Archer SL, Nelson DP, Weir EK. Chronic
EDRF inhibition and hypoxia: effects on pulmonary circulation
and systemic blood pressure. J Appl
Physiol. 1993;75:1748-1757.
16.
Rengasamy A, Johns RA. Characterization of
endothelium-derived relaxing factor/nitric oxide
synthase from bovine cerebellum and mechanism of modulation by high and
low oxygen tensions. J Pharmacol Exp Ther. 1991;259:310-316.
17.
Shultz PJ, Schorer AE, Raij L. Effects of
endothelium-derived relaxing factor and nitric oxide on
rat mesangial cells. Am J Physiol. 1990;258:F162-F167.
18.
Shultz PJ, Tayeh MA, Marletta MA, Raij L.
Synthesis and action of nitric oxide in rat glomerular mesangial
cells. Am J Physiol. 1991;261:F600-F606.
19. Zafiriou OC, McFarland M. Determination of trace levels of nitric oxide in aqueous solution. Anal Chem. 1980;52:1662-1667.
20.
Archer SL, Cowan NJ. Measurement of endothelial
cytosolic calcium concentration and nitric oxide production reveals
discrete mechanisms of endothelium-dependent pulmonary
vasodilation. Circ Res. 1991;68:1569-1581.
21. Fontijn A, Sabadell AJ, Ronco RJ. Homogeneous chemiluminescent measurement of nitric oxide with ozone. Anal Chem. 1970;42:575-579.
22. Archer S. Measurement of nitric oxide in biological models. FASEB J. 1993;7:349-360. [Abstract]
23. Archer SL, Shultz PJ, Warren JB, Hampl V, DeMaster EG. Preparation of standards and measurements of nitric oxide, nitroxyl and related oxidation products. Methods Enzymol. 1995;7:21-34.
24. Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest. 1992;90:1718-1725.
25.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ.
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951;193:265-275.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159. [Medline] [Order article via Infotrieve]
27. Correa-Rotter R, Mariash CN, Rosenberg ME. Loading and transfer control for Northern hybridization. Biotechniques. 1992;12:154-158. [Medline] [Order article via Infotrieve]
28.
Kunz D, Muhl H, Walker G, Pfeilschifter J. Two
distinct signaling pathways trigger the expression of inducible nitric
oxide synthase in rat mesangial cells. Proc Natl Acad Sci
U S A. 1994;91:5387-5391.
29.
McQuillan L, Leung GK, Marsden PA, Kostyk SK,
Kourembanas S. Hypoxia inhibits expression of eNOS via
transcriptional and posttranscriptional mechanisms. Am J
Physiol. 1994;267:H1921-H1927.
30. Raij L, Shultz PJ. Endothelium-derived relaxing factor, nitric oxide: effects on and production by mesangial cells and the glomerulus. J Am Soc Nephrol. 1993;3:1435-1441. [Abstract]
31. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro LJ. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. Adv Cyclic Nucleotide Res. 1979;5:211-224.
32. Murad F, Arnold W, Mittal CK, Braughler JM. Properties and regulation of guanylate cyclase and some proposed functions for cyclic GMP. Adv Cyclic Nucleotide Res. 1979;11:175-204. [Medline] [Order article via Infotrieve]
33. Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J. 1993;7:328-338.[Abstract]
34.
Cornwell TL, Lincoln TM. Regulation of
intracellular Ca2+ levels in cultured vascular
smooth muscle cells: reduction of Ca2+ by
atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent
protein kinase. J Biol Chem. 1989;264:1146-1155.
35.
Robertson BE, Schubert R, Hescheler J, Nelson M.
cGMP-dependent protein kinase activates Ca-activated K channels
in cerebral artery smooth muscle cells. Am J
Physiol. 1993;265:C299-C303.
36.
Archer SL, Huang JMC, Hampl V, Nelson DP, Shultz PJ,
Weir EK. Nitric oxide and cGMP cause vasorelaxation by
sGMP-kinase-dependent activation of a charybdotoxin-sensitive K
channel. Proc Natl Acad Sci U S A. 1994;91:7583-7587.
37.
Twort CHC, van Breemen C. Cyclic guanosine
monophosphate-enhanced sequestration of Ca2+ by
sarcoplasmic reticulum in vascular smooth muscle.
Circ Res. 1988;62:961-964.
38.
Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, Byrns
RE. Oxidation of nitric oxide in aqueous solution to nitrite but
not nitrate: comparison with enzymatically formed nitric oxide from
L-arginine. Proc Natl Acad Sci U S A. 1993;90:8103-8107.
39. Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol. 1992;5:834-842. [Medline] [Order article via Infotrieve]
40. Tojo A, Gross SS, Zhang L, Tisher C, Schmidt HHHW, Wilcox CS, Madsen KM. Immunocytochemical localization of distinct isoforms of nitric oxide synthase in the juxtaglomerular apparatus of normal rat kidney. J Am Soc Nephrol. 1994;4:1438-1447. [Abstract]
41. Mohaupt M, Elzie JL, Ahn KY, Clapp WL, Wilcox CS, Kone BC. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int. 1994;46:653-665. [Medline] [Order article via Infotrieve]
42. De Nicola L, Blantz RC, Gabbai FB. Nitric oxide and angiotensin II. J Clin Invest. 1992;89:1248-1256.
43. Shultz PJ, Tolins JP. Adaptation to increased dietary salt intake in the rat: role of endogenous nitric oxide. J Clin Invest. 1993;91:642-650.
44.
Yu L, Gengaro PE, Niederberger M, Burke TJ, Schrier RW.
Nitric oxide: a mediator in rat tubular hypoxia
/reoxygenation injury. Proc Natl Acad Sci U S A. 1993;91:1691-1695.
This article has been cited by other articles:
![]() |
M. A. Robinson, J. E. Baumgardner, V. P. Good, and C. M. Otto Physiological and hypoxic O2 tensions rapidly regulate NO production by stimulated macrophages Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1079 - C1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Land and C. Rae iNOS initiates and sustains metabolic arrest in hypoxic lung adenocarcinoma cells: mechanism of cell survival in solid tumor core Am J Physiol Cell Physiol, October 1, 2005; 289(4): C918 - C933. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grilli, M. A. De Lutiis, A. Patruno, L. Speranza, A. Cataldi, L. Centurione, A. A. Taccardi, P. Di Napoli, R. De Caterina, R. Barbacane, et al. Effect of Chronic Hypoxia on Inducible Nitric Oxide Synthase Expression in Rat Myocardial Tissue Experimental Biology and Medicine, September 1, 2003; 228(8): 935 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Michelakis, W. Tymchak, D. Lien, L. Webster, K. Hashimoto, and S. Archer Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide Circulation, May 21, 2002; 105(20): 2398 - 2403. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Mark and T. P. Davis Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1485 - H1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Pitt and C. M. St. Croix Complex Regulation of iNOS in Lung Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 6 - 9. [Full Text] [PDF] |
||||
![]() |
C. R. Ferreiro, A. C. P. Chagas, M. H. C. Carvalho, A. P. Dantas, M. B. Jatene, L. C. Bento de Souza, and P. Lemos da Luz Influence of Hypoxia on Nitric Oxide Synthase Activity and Gene Expression in Children With Congenital Heart Disease : A Novel Pathophysiological Adaptive Mechanism Circulation, May 8, 2001; 103(18): 2272 - 2276. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Otto and J. E. Baumgardner Effect of culture PO2 on macrophage (RAW 264.7) nitric oxide production Am J Physiol Cell Physiol, February 1, 2001; 280(2): C280 - C287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, L. He, S. H. Ahmed, S.-W. Chen, M. P. Goldberg, J. S. Beckman, C. Y. Hsu, and C. Iadecola Oxygen-Glucose Deprivation Induces Inducible Nitric Oxide Synthase and Nitrotyrosine Expression in Cerebral Endothelial Cells Editorial Comment Stroke, July 1, 2000; 31(7): 1744 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. KAKOKI, Y. HIRATA, H. HAYAKAWA, E. SUZUKI, D. NAGATA, A. TOJO, H. NISHIMATSU, N. NAKANISHI, Y. HATTORI, K. KIKUCHI, et al. Effects of Tetrahydrobiopterin on Endothelial Dysfunction in Rats with Ischemic Acute Renal Failure J. Am. Soc. Nephrol., February 1, 2000; 11(2): 301 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Ganz and A. Seftel Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E146 - E152. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, D. M. Rodman, and I. F. McMurtry Hypoxia inhibits increased ETB receptor-mediated NO synthesis in hypertensive rat lungs Am J Physiol Lung Cell Mol Physiol, April 1, 1999; 276(4): L571 - L581. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumar, R. Brar, P. Wang, L. Dee, G. Skorupa, F. Khadour, R. Schulz, and J. E. Parrillo Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R265 - R276. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sethi, M. P. Singh, and M. Dikshit Nitric Oxide-Mediated Augmentation of Polymorphonuclear Free Radical Generation After Hypoxia-Reoxygenation Blood, January 1, 1999; 93(1): 333 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kacimi, C. S. Long, and J. S. Karliner Chronic Hypoxia Modulates the Interleukin-1ß–Stimulated Inducible Nitric Oxide Synthase Pathway in Cardiac Myocytes Circulation, September 16, 1997; 96(6): 1937 - 1943. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |